ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.
作者信息
Jensen Robert T, Cadiot Guillaume, Brandi Maria L, de Herder Wouter W, Kaltsas Gregory, Komminoth Paul, Scoazec Jean-Yves, Salazar Ramon, Sauvanet Alain, Kianmanesh Reza
机构信息
Digestive Diseases Branch, NIH, Bethesda, MD 20892, USA.
出版信息
Neuroendocrinology. 2012;95(2):98-119. doi: 10.1159/000335591. Epub 2012 Feb 15.
Abstract
摘要
相似文献
1
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.
Neuroendocrinology. 2012;95(2):98-119. doi: 10.1159/000335591. Epub 2012 Feb 15.
2
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.
Neuroendocrinology. 2012;95(2):120-34. doi: 10.1159/000335587. Epub 2012 Feb 15.
3
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5.
4
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5.
5
Rare functioning pancreatic endocrine tumors.
Neuroendocrinology. 2006;84(3):189-95. doi: 10.1159/000098011. Epub 2007 Feb 20.
6
Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group.
Ann Surg Oncol. 2015 Aug;22(8):2685-99. doi: 10.1245/s10434-014-4145-0. Epub 2014 Nov 4.
7
[Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):982-986.
8
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Neuroendocrinology. 2009;90(2):162-6. doi: 10.1159/000182196. Epub 2009 Aug 28.
9
Pancreatic neuroendocrine tumors: a review.
Future Oncol. 2015;11(5):853-64. doi: 10.2217/fon.14.285.
10
[Gastrointestinal and pancreatic neuroendocrine tumors].
Med Clin (Barc). 2006 Jul 8;127(6):227-31. doi: 10.1157/13091016.
引用本文的文献
1
Nutritional Management of Functioning GEP-NENs.
Nutrients. 2025 Jun 30;17(13):2175. doi: 10.3390/nu17132175.
2
Recurrence of malignant insulinoma in the context of multiple endocrine neoplasia type 1: a case report.
J Surg Case Rep. 2025 May 22;2025(5):rjaf335. doi: 10.1093/jscr/rjaf335. eCollection 2025 May.
3
Multimodal Imaging Approach to MEN-1 Syndrome-Associated Tumors.
Diagnostics (Basel). 2025 May 3;15(9):1164. doi: 10.3390/diagnostics15091164.
4
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolism.
J Endocrinol Invest. 2025 Apr 28. doi: 10.1007/s40618-025-02589-2.
5
Multicenter Study on the Clinical Characteristics, Diagnosis, and Treatment Outcomes of Insulinoma: Insights From 15 Medical Centres.
Clin Endocrinol (Oxf). 2025 Jul;103(1):57-65. doi: 10.1111/cen.15255. Epub 2025 Apr 25.
6
Anaesthesia for pancreatic resection surgery: part 1.
BJA Educ. 2025 Feb;25(2):57-64. doi: 10.1016/j.bjae.2024.10.001. Epub 2024 Nov 22.
7
Endoscopic-Ultrasound-Guided Radiofrequency Ablation for Pancreatic Tumors.
J Clin Med. 2025 Jan 14;14(2):495. doi: 10.3390/jcm14020495.
8
Insulinoma With Ambiguous Biochemistry, Positive Ga-DOTA-Exendin-4 PET-CT, and Effective Endoscopic Ablation.
JCEM Case Rep. 2025 Jan 9;3(1):luae232. doi: 10.1210/jcemcr/luae232. eCollection 2025 Jan.
9
Role of Endoscopic Ultrasound-Guided Radiofrequency Ablation in Pancreatic Lesions: Where Are We Now and What Does the Future Hold?
Cancers (Basel). 2024 Oct 30;16(21):3662. doi: 10.3390/cancers16213662.
10
Metastatic insulinoma-outcomes in the current era.
Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyae275.
本文引用的文献
1
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
Neuroendocrinology. 2012;95(2):157-76. doi: 10.1159/000335597. Epub 2012 Feb 15.
2
The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment.
Clin Gastroenterol Hepatol. 2012 Feb;10(2):199-202. doi: 10.1016/j.cgh.2011.08.012. Epub 2011 Aug 24.
3
Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Gut. 2011 Jul;60(7):1009-21. doi: 10.1136/gut.2009.204453. Epub 2011 Mar 4.
4
The Zollinger-Ellison syndrome and mismeasurement of gastrin.
Gastroenterology. 2011 May;140(5):1444-53. doi: 10.1053/j.gastro.2011.01.051. Epub 2011 Mar 23.
5
Promising advances in the treatment of malignant pancreatic endocrine tumors.
N Engl J Med. 2011 Feb 10;364(6):564-5. doi: 10.1056/NEJMe1013903.
6
Everolimus for advanced pancreatic neuroendocrine tumors.
N Engl J Med. 2011 Feb 10;364(6):514-23. doi: 10.1056/NEJMoa1009290.
7
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
N Engl J Med. 2011 Feb 10;364(6):501-13. doi: 10.1056/NEJMoa1003825.
8
Validation of five contemporary prognostication systems for primary pancreatic endocrine neoplasms: results from a single institution experience with 61 surgically treated cases.
ANZ J Surg. 2011 Jan;81(1-2):79-85. doi: 10.1111/j.1445-2197.2010.05403.x. Epub 2010 Aug 27.
9
Setting the bar for laparoscopic resection of sporadic insulinoma.
World J Surg. 2011 Apr;35(4):785-9. doi: 10.1007/s00268-011-0970-5.
10
Surgical management of patients with insulinomas: Result of 292 cases in a single institution.
J Surg Oncol. 2011 Feb;103(2):169-74. doi: 10.1002/jso.21773. Epub 2010 Dec 22.
Zotero 插件